- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04453865
Empowering Anxious Parents to Manage Child Avoidance Behaviors (EMPOWER)
Empowering Anxious Parents to Manage Child Avoidance Behaviors: A Randomized Trial of a Single-Session Intervention Targeting Parent Accommodation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anxiety disorders are among the most common, debilitating forms of childhood psychopathology, affecting 8.3-27.0% of youth before the age of 18. Child anxiety increases risk for psychiatric comorbidities across the lifespan) creates significant burdens for caregivers, and carries societal costs. Although numerous interventions have been developed to treat youth anxiety disorders, up to 82.2% of US youth with anxiety will not receive adequate care. Several reasons may explain this discrepancy, including the length and cost of existing evidence-based interventions (EBIs) and limited accessibility for families in need.
Single-session interventions (SSIs) may offer one potential solution to this gap in care. SSIs include core components of comprehensive EBIs delivered succinctly to improve the odds of access and completion. In a recent meta-analysis of 50 RCTs, SSIs reduced youth mental health problems of multiple disorders, with SSIs targeting child anxiety producing the largest effects (mean g = 0.58). Thus, well-targeted SSIs may offer cost-effective additions or alternatives to traditional care for anxiety in youth. However, most existing SSIs for child anxiety target populations already experiencing clinical distress, and a need remains for options that may prevent anxiety in vulnerable children. Given that family factors play a crucial role in the etiology of child anxiety, SSIs targeting parents and their interactions with offspring offer a novel approach to preventing youth anxiety. Thus, the aim of this project is to test the acceptability and short-term effects of a novel, web-based SSI targeting parental accommodation: a well-established, potentially modifiable risk factor for child anxiety. Results may reveal a promising, targeted approach to scalable child anxiety prevention.
Parental Accommodation as a Modifiable Intervention Target. Parent accommodation refers to changes in caregiver behaviors that facilitate or maintain their child's avoidance or anxiety. Examples include modifying family routines (i.e., staying home from work to alleviate a child's fear of separating) or directly participating in a child's avoidance strategies (i.e., keeping a child home from school). Parent accommodation reduces immediate distress but maintains long-term avoidance of feared stimuli or situations and high levels of parent accommodation are associated with anxiety problems in offspring. Parent accommodation is further maintained by caregiver factors, including parental anxiety and tolerance for distress. For instance, accommodation is greater among parents reporting higher distress about their child's anxiety symptoms and perceptions that anxiety exposure is harmful for youth.
Research shows that parent accommodation can be systematically reduced via psychosocial intervention, and interventions targeting accommodation have helped mitigate child anxiety. Translating core components of existing interventions that target parental accommodation into briefer, self-administered SSIs (i.e., those that do not involve a trained therapist) may improve families' access to empirically-driven supports for child anxiety. It may also enhance the implementation of mental health interventions by lay providers who frequently interact with children (e.g. teachers and pediatricians). Thus, the goal of this project is to test a web-based, self-guided SSI targeting parental accommodation. Parent participants will be randomized to either (a) Online Resources and Referrals (ORR) + parent accommodation SSI, or (b) ORR alone and delayed SSI access. We predict that parents will report larger declines in accommodation in the ORR+Accommodation SSI group, relative to the ORR + delayed SSI access group, from baseline to 2-week follow-up. We also predict that parents will perceive significant pre-to immediate-post-SSI increases in their ability to help their child manage distressing situations. Finally, we predict that participants will find the SSI to be acceptable.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794-2500
- Stony Brook University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Report subclinical or greater anxiety symptoms, per a score of 40 or higher on the Penn State Worry Questionnaire (PSWQ)
- Have at least one child between the ages of 4-10 years old
- Live in the United States (US)
Exclusion Criteria:
1. Participant is non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Project EMPOWER
Project EMPOWER is a web-based, self-administered SSI for parents that takes about 30 minutes to complete.
The program includes 5 elements, based on current best-practices in SSI design (Schleider, Dobias, Sung, & Mullarkey, 2020) and existing interventions targeting accommodation (Lebowitz & Omer, 2014): (1) an introduction to the program's rationale; (2) psychoeducation around child anxiety and avoidance, along with how parental accommodation can inadvertently maintain child anxiety; (3) information on how parents can better identify children's patterns of avoidance and encourage brave behavior instead; (4) facilitating parents' creation of an "action plan" for promoting brave behavior and reduce avoidance in their own child; (5) a vignette exercise in which parents read about another family's difficulty managing their child's anxiety; parents identify the elements of the anxiety cycle and provide possible solutions to these parents based on what they learned.
|
Project EMPOWER is a web-based, self-administered SSI for parents that takes about 30 minutes to complete
|
Other: Online Resources and Referrals (ORR)
Online Resources and Referrals (ORR) is an information sheet containing materials about the nature of child anxiety and a list of national resources related anxiety treatment.
ORR does not include any psychoeducational components regarding parental accommodation.
|
Information sheet containing materials about the nature of child anxiety and a list of national resources related anxiety treatment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Family Accommodation Scale
Time Frame: Change from Baseline Accommodation at 2-week follow up
|
Family Accommodation Scale is a 9-item measure designed to assess the extent a caregiver accommodate a child's anxiety symptoms; example questions include: "how often did you assist your child in avoiding things that might make him/her more anxious?"
and "have you modified your family routine because of your child's symptoms?"
Items are rated from 0 (never) to 4 (daily).
Scores range from 0-36 with higher scores indicating more frequent parental accommodation.
|
Change from Baseline Accommodation at 2-week follow up
|
Perceived pre-to-post SSI change
Time Frame: Immediately after the SSI
|
This single-item measure assesses participants' perceived change in their ability to help their children manage distressing situations from pre- to post-SSI: "compared to before you completed this program, how prepared do you feel to help your child manage distressing situations?" Parents in both groups will rate this question on a 5-point scale of 1 (much less able to help child manage distressing situations) to 5 (much more able to to help child manage distressing situations).
|
Immediately after the SSI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Program Feedback Scale
Time Frame: Immediately after the SSI
|
The program feedback scale asks participants to rate 7 statements regarding acceptability and feasibility; note whether they would recommend this activity to others; and share what they liked and would change about the SSI.
The 7 statements are rated from 0 (Really Disagree) to 5 (Really Agree).
Total score ranges from 0 to 35, with higher scores indicating a more positive program evaluation.
|
Immediately after the SSI
|
Penn State Worry Questionnaire
Time Frame: Baseline
|
16 item self-report questionnaire that asks individuals to rate how typical worry-related problems are for them, from 1 (not at all typical) to 5 (very typical).
Scores range from 16-80; higher scores indicate more severe worry.
|
Baseline
|
Coping with Children's Negative Emotions Scale
Time Frame: Baseline
|
Coping with Children's Negative Emotions Scale measures parents' reactive emotions to their child's negative affect in distressing situations.
Six subscales exist, but only the "distress reactions" domain, reflecting parental distress in the context of child negative affect, will be used.
Participants rate 12 questions from 1 (very unlikely) to 7 (very likely).
Score ranges from 12-84; higher numbers indicate more distress.
|
Baseline
|
Revised Children's Anxiety and Depression Scale
Time Frame: Baseline
|
25 item measure assessing child's symptoms of anxiety and depression.
Each question is rated on a 4-point scale from 0 (Never) to 3 (Always).
Total score ranges from 0 to 75 with higher scores indicating higher levels of psychopathology
|
Baseline
|
Barriers to Access to Care Evaluation
Time Frame: Baseline
|
30 item self-report questionnaire that asks about barriers they faced in getting professional care for a mental health problem on a scale of 0 (not at all) to 3 (a lot).
Scores range from 0 to 90; higher scores indicate a higher number of barriers.
|
Baseline
|
Adult Measure of Behavioral Inhibition
Time Frame: Baseline
|
16 item measure assessing one's temperamental tendency to respond to social novelty and risk stimuli, with inhibition and avoidance.
Each question is rated on a 3 point scale from 0 (no/hardly ever) and 2 (yes/most of the time).
Total score ranges from 0 to 32 with a higher scores indicating a greater degree of inhibition.
|
Baseline
|
Short Behavioral Inhibition Questionnaire
Time Frame: Baseline
|
14-item parent rated scale measuring temperamental characteristics referring to shyness, fearfulness, and withdrawal in young, preschool children.
Each question is rated on a 7-point scale from 1 (Hardly Ever) to 7 (Almost Always).
Total score ranges from 14 to 98, with higher scores indicating a greater degree of inhibition
|
Baseline
|
Ruminative Response Scale
Time Frame: Baseline
|
22 item questionnaire measuring two aspects of rumination: brooding and reflective pondering.
Each question is rated on a 4-point scale from 1 (almost never) and 4 (almost always).
Total score ranges from 22 to 88 with a higher score indicating higher ruminative tendencies.
|
Baseline
|
Distress Tolerance Scale
Time Frame: Change from Baseline Coping at 2-week follow up
|
16 item measure assessing the extent to which one experiences and withstand distressing emotional states.
Each item is rated on a 5-point Likert scale from 1 (strongly agree) and 5 (strongly disagree).
Total score ranges from 16 to 80 with a higher score indicating higher levels of distress tolerance.
|
Change from Baseline Coping at 2-week follow up
|
Co-Rumination Questionnaire
Time Frame: Baseline
|
27-item self-report inventory that measures the extent to which one co-ruminates with others.
For brevity, the survey has been modified to consist of 8 items that range from 1 (Not at all true) to 5 (really true).
Total score ranges from 8 to 40 with a higher score indicating higher levels of co-rumination.
|
Baseline
|
Patient Reported Outcomes Measurement Information System-Depression Short
Time Frame: Baseline
|
8 item self-report measure of depression.
The questions are rated on a 5-point scale ranging from 1 (never) to 5 (always).
Scores range from 8 to 40m higher scores indicating higher levels of depression.
|
Baseline
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Schleider JL, Weisz JR. Little Treatments, Promising Effects? Meta-Analysis of Single-Session Interventions for Youth Psychiatric Problems. J Am Acad Child Adolesc Psychiatry. 2017 Feb;56(2):107-115. doi: 10.1016/j.jaac.2016.11.007. Epub 2016 Nov 25.
- Beecham J. Annual research review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders. J Child Psychol Psychiatry. 2014 Jun;55(6):714-32. doi: 10.1111/jcpp.12216. Epub 2014 Feb 28.
- Bodden DH, Dirksen CD, Bogels SM. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study. J Abnorm Child Psychol. 2008 May;36(4):487-97. doi: 10.1007/s10802-007-9194-4. Epub 2008 Jan 23.
- Copeland WE, Angold A, Shanahan L, Costello EJ. Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):21-33. doi: 10.1016/j.jaac.2013.09.017. Epub 2013 Oct 12.
- Costello EJ, Egger HL, Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am. 2005 Oct;14(4):631-48, vii. doi: 10.1016/j.chc.2005.06.003.
- Degnan KA, Almas AN, Fox NA. Temperament and the environment in the etiology of childhood anxiety. J Child Psychol Psychiatry. 2010 Apr;51(4):497-517. doi: 10.1111/j.1469-7610.2010.02228.x. Epub 2010 Feb 11.
- Edlund MJ, Unutzer J, Curran GM. Perceived need for alcohol, drug, and mental health treatment. Soc Psychiatry Psychiatr Epidemiol. 2006 Jun;41(6):480-7. doi: 10.1007/s00127-006-0047-1. Epub 2006 Mar 25.
- Kendall, P. C., Aschenbrand, S. G., & Hudson, J. L. (2003). Child-focused treatment of anxiety. Evidence-Based Psychotherapies for Children and Adolescents, 81-100.
- Lebowitz, E. R., Omer, H., Hermes, H., & Scahill, L. (2014). Parent Training for Childhood Anxiety Disorders: The SPACE Program. Cognitive and Behavioral Practice, 21(4), 456- 469. https://doi.org/10.1016/j.cbpra.2013.10.004
- Lebowitz ER, Panza KE, Su J, Bloch MH. Family accommodation in obsessive-compulsive disorder. Expert Rev Neurother. 2012 Feb;12(2):229-38. doi: 10.1586/ern.11.200.
- Lebowitz ER, Scharfstein L, Jones J. Child-Report of Family Accommodation in Pediatric Anxiety Disorders: Comparison and Integration with Mother-Report. Child Psychiatry Hum Dev. 2015 Aug;46(4):501-11. doi: 10.1007/s10578-014-0491-1.
- Merikangas KR, He JP, Burstein M, Swendsen J, Avenevoli S, Case B, Georgiades K, Heaton L, Swanson S, Olfson M. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):32-45. doi: 10.1016/j.jaac.2010.10.006. Epub 2010 Dec 3.
- Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PS, Wells KB, Pincus HA, Kessler RC. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011 Aug;41(8):1751-61. doi: 10.1017/S0033291710002291. Epub 2010 Dec 7.
- Ramos-Cerqueira AT, Torres AR, Torresan RC, Negreiros AP, Vitorino CN. Emotional burden in caregivers of patients with obsessive-compulsive disorder. Depress Anxiety. 2008;25(12):1020-7. doi: 10.1002/da.20431.
- Salloum A, Johnco C, Lewin AB, McBride NM, Storch EA. Barriers to access and participation in community mental health treatment for anxious children. J Affect Disord. 2016 May 15;196:54-61. doi: 10.1016/j.jad.2016.02.026. Epub 2016 Feb 10.
- Schleider JL, Dobias ML, Sung JY, Mullarkey MC. Future Directions in Single-Session Youth Mental Health Interventions. J Clin Child Adolesc Psychol. 2020 Mar-Apr;49(2):264-278. doi: 10.1080/15374416.2019.1683852. Epub 2019 Dec 4.
- Schleider JL, Mullarkey MC, Weisz JR. Virtual Reality and Web-Based Growth Mindset Interventions for Adolescent Depression: Protocol for a Three-Arm Randomized Trial. JMIR Res Protoc. 2019 Jul 9;8(7):e13368. doi: 10.2196/13368.
- Schleider, J. L., & Weisz, J. R. (2017a). Can less be more? The promise (and perils) of single session youth mental health interventions. The Behavior Therapist, 40(7), 256-261.
- Settipani CA, Kendall PC. The Effect of Child Distress on Accommodation of Anxiety: Relations With Maternal Beliefs, Empathy, and Anxiety. J Clin Child Adolesc Psychol. 2017 Nov-Dec;46(6):810-823. doi: 10.1080/15374416.2015.1094741. Epub 2015 Dec 16.
- Storch, E. A., Lehmkuhl, H., Pence, S. L., Geffken, G. R., Ricketts, E., Storch, J. F., & Murphy, T. K. (2009). Parental experiences of having a child with obsessive-compulsive disorder: Associations with clinical characteristics and caregiver adjustment. Journal of Child and Family Studies, 18(3), 249-258.
- Thompson-Hollands J, Kerns CE, Pincus DB, Comer JS. Parental accommodation of child anxiety and related symptoms: range, impact, and correlates. J Anxiety Disord. 2014 Dec;28(8):765-73. doi: 10.1016/j.janxdis.2014.09.007. Epub 2014 Sep 16.
- Sung JY, Mumper E, Schleider JL. Empowering Anxious Parents to Manage Child Avoidance Behaviors: Randomized Control Trial of a Single-Session Intervention for Parental Accommodation. JMIR Ment Health. 2021 Jul 6;8(7):e29538. doi: 10.2196/29538.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2020-00069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Loma Linda UniversityCompletedParental/Caregiver Anxiety | Child's AnxietyUnited States
Clinical Trials on Project EMPOWER
-
Massachusetts General HospitalAIM Youth Mental HealthRecruitingAnxiety DisordersUnited States
-
Stony Brook UniversityRobert Wood Johnson FoundationNot yet recruitingProject EMPOWER | Online Resources and Referrals
-
Göteborg UniversityKarolinska University Hospital; The Swedish Research Council; Swedish Council... and other collaboratorsRecruiting
-
University of RochesterWithdrawnHeart FailureUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Recruiting
-
Pace UniversityNot yet recruitingChronic Disease
-
VA Office of Research and DevelopmentActive, not recruitingBenzodiazepine Dependence | Taking Benzodiazepines for Any Reason for 3 MonthsUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnInformal CaregiverUnited States
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland